NeoFuse
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Cervical Degenerative Disc Disease
Conditions
Cervical Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis
Trial Timeline
Jun 1, 2010 → Jul 1, 2014
NCT ID
NCT01097486About NeoFuse
NeoFuse is a phase 2 stage product being developed by Mesoblast for Cervical Degenerative Disc Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT01097486. Target conditions include Cervical Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis.
What happened to similar drugs?
8 of 20 similar drugs in Cervical Degenerative Disc Disease were approved
Approved (8) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
12
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01097486 | Phase 2 | Completed |
| NCT01106417 | Phase 1/2 | Completed |
| NCT00549913 | Phase 1/2 | Completed |
Competing Products
20 competing products in Cervical Degenerative Disc Disease